- What changed in TELO news today?
- Telomir Pharmaceuticals prices $5.6 million PIPE at $1.16 per share: Telomir Pharmaceuticals priced a $5.6 million private placement of 4,843,300 common shares at $1.16 each, a 5% discount to the applicable 10-day VWAP. Proceeds will mainly fund Telomir-Zn clinical development, including a Phase 1/2 trial in advanced or metastatic triple-negative breast cancer.
- Does Rallies summarize TELO news?
- Yes. Rallies summarizes TELO news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
- Is TELO research on Rallies investment advice?
- No. Rallies provides research, data, and educational context for TELO. It does not provide personalized investment advice.